Back
Kronos Worldwide 10K Form
Buy
57
KRO
Kronos Worldwide
Last Price:
$6.46
Seasonality Move:
1.82%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-08 | 10Q | KRO/Kronos Worldwide Quarterly |
| 2023-11-02 | 10Q | KRO/Kronos Worldwide Quarterly |
| 2023-08-02 | 10Q | KRO/Kronos Worldwide Quarterly |
| 2023-05-03 | 10Q | KRO/Kronos Worldwide Quarterly |
| 2022-11-02 | 10Q | KRO/Kronos Worldwide Quarterly |
| 2022-08-03 | 10Q | KRO/Kronos Worldwide Quarterly |
Receive KRO News And Ratings
See the #1 stock for the next 7 days that we like better than KRO
KRO Financial Statistics
Sales & Book Value
| Annual Sales: | $1.9B |
|---|---|
| Cash Flow: | $-114.4M |
| Price / Cash Flow: | 19.31 |
| Annual Sales: | $7.36 |
| Price / Book: | 0.86 |
Profitability
| EPS (TTM): | 0.83000 |
|---|---|
| Net Income (TTM): | $96.2M |
| Gross Margin: | $359.3M |
| Return on Equity: | 11.85% |
| Return on Assets: | 5.28% |
Kronos Worldwide Earnings Forecast
Key Kronos Worldwide Financial Ratios
-
The Gross Profit Margin over the past 22 years for KRO is 19.04%.
-
The Selling, General & Administrative Expenses for KRO have been equal to 11.95% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 49.77% of Operating Income.
-
The Net Earning history of KRO is 4.57% of Total Revenues.
-
Per Share Earnings over the last 26 years have been positive in 13 years.
Kronos Worldwide Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Chemicals |
| Sector: | Materials |
| Current Symbol: | KRO |
| CUSIP: | 50105F |
| Website: | kronosww.com |
Debt
| Debt-to-Equity Ratio: | 0.66 |
|---|---|
| Current Ratio: | 2.62 |
| Quick Ratio: | 0.87 |
Price-to-Earnings
| Trailing P/E Ratio: | 8.47 |
|---|---|
| Forward P/E Ratio: | 5.64 |
KRO Technical Analysis vs Fundamental Analysis
Buy
57
Kronos Worldwide (KRO)
is a Buy
Is Kronos Worldwide a Buy or a Sell?
-
Kronos Worldwide stock is rated a BuyThe current Kronos Worldwide [KRO] share price is $6.35. The Score for KRO is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.